Unlocking nitrogen compounds' promise against malaria: A comprehensive review

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Plasmodium parasites cause malaria, a disease with high mortality rates.
• Existing antimalarial drugs, including Artemisinin combination therapy (ACT), face increasing resistance due to parasite mutations.
• There is a critical need for novel, safe, effective, and affordable antimalarial scaffolds.

Purpose of the Study:

• To review recent advancements in antimalarial medication development.
• To provide a concise overview of emerging scaffolds for antimalarial drug discovery.
• To emphasize 1,4-benzodiazepines as a novel scaffold for combating malaria.

Main Methods:

• Literature review of potent antimalarial molecules and scaffolds.
• Analysis of nitrogen-containing heterocycles explored for antimalarial activity.
• Focus on the emerging role of benzodiazepines in antimalarial research.

Main Results:

• Nitrogen-containing heterocycles like β-carboline, imidazole, quinazoline, quinoline, thiazole, and thiophene have shown significant antimalarial potential.
• 1,4-Benzodiazepines, traditionally used as CNS depressants, are emerging as a promising scaffold for antimalarial drug discovery.
• This review consolidates data on diverse scaffolds to offer a comprehensive overview.

Conclusions:

• The emergence of drug resistance necessitates the exploration of novel antimalarial scaffolds.
• 1,4-Benzodiazepines represent a novel and promising scaffold for developing new antimalarial agents.
• Continued research into diverse chemical scaffolds is crucial for overcoming malaria treatment challenges.